Previous 10 | Next 10 |
Deutsche Bank analyst George Hill writes that although COVID-19 has disrupted the retail pharmacy business, Rite Aid (RAD) is poised as a "positive opportunity" in both the near and long terms.He has initiated a short-term buy rating.Yesterday, Rite Aid shares fell significantly in afte...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Stuck in SuezTugs and diggers have so far failed to dislodge the Ever Given, a massive container ship stuck in the Suez Canal after losing the ability to s...
Rite Aid (RAD) is updating its fiscal year 2021 guidance downwards in the face of what it calls a weak cold and flu season, the ongoing effects of COVID-19, and weather events that impacted a large portion of the country.Rite Aid's FY 21 Q4 ended on February 27 and the company will release re...
Fourth Quarter Results Significantly Impacted by Weak Cough, Cold and Flu Season, Continued Effects Related to the COVID-19 Pandemic and Difficult Weather Conditions Fiscal 2021 Net Loss is Now Expected to be Between $90 Million and $100 Million Fiscal 2021 Adjusted ...
Our job as investors is to pay attention to the stocks we own. Part of that involves looking at the fundamentals, but half of the disclosure comes from looking at price action. The Rite Aid (NYSE: RAD) data table below can help you with price action, and we have more details too. ...
Rite Aid today announced it has extended the priority COVID-19 vaccine scheduling period for teachers, school staff and childcare providers, in accordance with a directive from the United States Department of Health and Human Services (HHS) and the Biden Administration, to ensure these ...
Rite Aid has a growing retail pharmacy business generating over $15 billion in annual revenues. RAD owns a Prescription Benefits Management (PBM) service, now known as Elixir, currently generating an additional $8 billion in annual revenues. Comparing revenue to market capitalizat...
CVS Health (CVS) and Rite Aid (RAD) are two of the largest pharmacies in the US. Pharmacy stocks have outperformed in recent months as many expect consumer spending to be quite strong in 2021 and 2022. Patrick Ryan breaks down which is the best pick for your portfolio. CVS Health ( CV...
The company has achieved 98% compliance on 2016 commitment to remove harmful chemicals in products sold Rite Aid (NYSE: RAD) today announced expanded commitments to reduce toxic chemicals in the products it sells, doubling down on its efforts to ensure clean, safe product in...
Influential Investors can create defining moments in a stock's price, by simply making large buy and sell decisions, and Rite Aid (NYSE: RAD) is no exception. Pivot points in a chart pattern are often created by these events, and as we have learned this does not require institutio...
News, Short Squeeze, Breakout and More Instantly...
Secures Interim Approval to Access Up to $3.45 Billion in Debtor-in-Possession Financing Continues to Serve Customers and Deliver Healthcare Products and Services Across Retail and Online Platforms Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Compan...
Stein Succeeds Elizabeth “Busy” Burr Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) today announced that its Board of Directors has appointed Jeffrey S. Stein as Chief Executive Officer (CEO), Chief Restructuring Officer (CRO) an...
Reaches Agreement in Principle with Key Creditors on the Terms of Financial Restructuring Plan Initiates Voluntary Chapter 11 Process to Implement a Consensual Financial Restructuring That Will Significantly Reduce Debt and Enable Execution of Key Initiatives Receives Commitment f...